Ascendis Health’s anchor investor, private equity firm Coast2Coast, says it is working on measures to shore up liquidity and put an end to its forced sales of the healthcare company’s stock. To meet obligations to lenders, Coast2Coast has been a heavy seller of Ascendis shares in recent weeks. The sales, to meet margin calls and to partly settle convertible debt instruments, have contributed to a precipitous share price decline. Ascendis’s shares closed at R3.50 on Wednesday, an 83% decline since Coast2Coast paid R20 a share during a rights offer just a year ago.

“Coast2Coast has initiated a number of projects, some of which are well progressed, which will provide additional liquidity ... at which point we expect to see an end to the current overhang on the Ascendis share,” said Coast2Coast CEO Gary Shayne, who is also an Ascendis board member. Coast2Coast also owns majority stakes in consumer goods companies Bounty Brands and Marlin Brands. It has been forced to rely on those...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.